1. Abraham E, Wunderink R, Silverman H, Perl TM, Nasraway S, Levy H, Bone R, Wenzel RP, Balk R, Allred R, Pennington JE, Wherry JC (1995) Efficacy and safety of monoclonal antibody to human tumor necrosis factor alpha in patients with sepsis syndrome: A randomized, controlled, double-blind, multicenter clinical trial. JAMA 273: 934–941 2. Alexander HR, Doherty GM, Venzon DJ, Merino MJ, Fraker DL, Norton JA (1992) Recombinant interleukin-1 receptor antagonist (IL-1ra) effective therapy against gram-negative sepsis in rats. Surgery 112: 188–193
2. American College of Chest Physicians/Society of Critical Care Medicine Consensus Conference (1992) Definitons for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. Crit Care Med 20: 864–874
3. Anderson BO, Bensard DD, Harken AH (1991) The role of platelet activating factor and its antagonists in shock, sepsis and multiple organ failure. Surgery 172: 415–424
4. Bakker J, Zhang H, Depierreux M, van Asbeck S, Vincent JL (1994) Effects of N-acetylcysteine in endotoxic shock. J Crit Care 9: 236–243
5. Balk RA, Parrillo JE (1992) Prognostic factors in sepsis. The cold facts [editorial]. Crit Care Med 20: 1373–1374